Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of HEMOCO is 0.3% (very low). The 2025 annual accounts show equity of €3.28M and a net result of €30k. Equity is shrinking by ~2.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 62 sector peers (fiscal year 2025). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 7 annual accounts.
Trust signals
3 signalsAdministrative Flags
0 eventsBankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB · 2025How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 99.0% | 13.5% | |
| Net result | €30k | €1k | |
| Equity | €3.28M | €14k | |
| Gross operating margin | €15k | €18k | |
| Total assets | €3.32M | €77k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €964 |
| Net profit | €30k |
| Cash flow | €90k |
| Staff costs | - |
| Income taxes | €3k |
| Dividends | - |
| Total assets | €3.32M |
| Equity | €3.28M |
| Debt | €32k |
| of which ≤ 1y | €5k |
| of which > 1y | €8k |
| Working capital | €3.08M |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 594.87 |
| Quick ratio | 594.87 |
| Working capital ratio | 92.9% |
| Solvency | 99.0% |
| Debt / equity | 0.01 |
| Long-term debt ratio | 0.00 |
| Interest coverage | 5.07 |
| Gross margin | - |
| Net margin | - |
| ROA | 0.9% |
| ROE | 0.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.32M |
| Fixed assets | 21/28 | €229k |
| Tangible fixed assets | 22/27 | €229k |
| Current assets | 29/58 | €3.09M |
| Amounts receivable within one year | 40/41 | €46k |
| Investments | 50/53 | €2.50M |
| Cash & bank | 54/58 | €476k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.32M |
| Equity | 10/15 | €3.28M |
| Contributions / capital | 10/11 | €6k |
| Reserves | 13 | €3.28M |
| Amounts payable | 17/49 | €32k |
| Amounts payable after one year | 17 | €8k |
| Amounts payable within one year | 42/48 | €5k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €15k |
| Operating result | 9901 | €-59k |
| Financial income | 75 | €93k |
| Financial charges | 65 | €190 |
| Result before taxes | 9903 | €33k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €30k |
| Result to be appropriated | 9905 | €30k |
Health barometer
FY 2025 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Structure & network
Locations & real estate
Establishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42007A1111/00D003 | Flanders | 2,282 m² | 1 · 1,518 m² | 10.3 m · 2 fl. |
| 42452B1277/00X000 | Flanders | 412 m² | 1 · 92 m² | 9.2 m · 2 fl. |
Analysis
Snowflake analysis
financial profile on 5 axesStrong profile, led by solvency.
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Largest companies in this sector: this company is among the largest, so we show the sector's topCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | HEMOCO |